Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 13, 2024 16:05 ET
|
Exagen Inc.
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following...
Exagen Inc. Reports Third Quarter 2024 Results
November 12, 2024 08:00 ET
|
Exagen Inc.
Expanded AVISE® CTD trailing twelve-month average selling priceReduced Adjusted EBITDA loss for first three quarters of 2024Revenue in line with expectations, excluding one-time adjustments CARLSBAD,...
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
October 29, 2024 16:05 ET
|
Exagen Inc.
CARLSBAD, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended September 30, 2024,...
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
October 21, 2024 16:05 ET
|
Exagen Inc.
CARLSBAD, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of five abstracts at the 2024 American College...
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 02, 2024 09:00 ET
|
Exagen Inc.
CARLSBAD, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 44th...
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
July 22, 2024 09:00 ET
|
Exagen Inc.
CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended June 30, 2024, before...
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
May 13, 2024 08:00 ET
|
Exagen Inc.
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31,...
Exagen Announces Campaign for Lupus Awareness Month
May 06, 2024 16:05 ET
|
Exagen Inc.
CARLSBAD, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch...
Exagen Inc. Announces Changes to the Board of Directors
April 26, 2024 08:30 ET
|
Exagen Inc.
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is...
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
March 18, 2024 08:00 ET
|
Exagen Inc.
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full...